Literature DB >> 15539881

Influences of gender and region on responses to 5-HT in the rat small intestine.

H Liu1, H R Irving, Y Y Tan, L Meng, N Chetty, I M Coupar.   

Abstract

The aim of this study was to obtain more information regarding the 'atypical' 5-HT7 receptor of the rat jejunum. 5-HT7-induced contractions of the jejunum were elicited by 5-HT in the presence of ondansetron. Maximal responses were slightly larger in tissues from male compared to female rats of comparable age, with Emax values of 97.2 +/- 3.3 and 84.25 +/- 4.3% respectively compared to acetylcholine as an internal standard. However, the pEC50 values for 5-HT were not significantly different. The mRNA expression levels of the 5-HT7 receptor were similar in whole jejunum and longitudinal muscle tissues taken from males and females. It was also shown that the maximal response of the jejunum from male rats was larger than the responses from mid intestine and ileum. However, in female tissues, the Emax of the mid intestine was significantly larger than the ileum, but not different from the jejunum. The results provide further insights into the 'atypical' 5-HT7 receptor of the rat jejunum and are also useful in optimising the preparation for further studies. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539881     DOI: 10.1159/000080376

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

1.  Activation of 5-HT3 receptors in the rat and mouse intestinal tract: a comparative study.

Authors:  Navinisha Chetty; Helen R Irving; Ian M Coupar
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

2.  Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.

Authors:  Shen-Hao Wang; Lei Dong; Jin-Yan Luo; Jun Gong; Lu Li; Xiao-Lan Lu; Shui-Ping Han
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.